Global Pneumococcal Vaccine Market Research Report 2012-2024
- HEY3239730
- 79 Pages
- July 2019
- Medical Devices
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. There are two types of Pneumococcal Vaccine: conjugate vaccines and polysaccharide vaccines.23-Valent Pneumococcal Polysaccharide Vaccine (PPSV 23) is polysaccharide vaccine. Pneumococcal conjugate vaccines contain PCV 7/13 (Pfizer) and PCV10 (GSK).
The global Pneumococcal Vaccine market will reach xxx Million USD in 2019 with CAGR xx% 2019-2024. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
PPSV 23
PCV 7/13
PCV 10
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
MSD
Sanofipasteur
CDIBP
Pfizer
GSK
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Infants
Children (2-10)
Person (10-64)
The old (≥65)
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
1.1.2 Specifications
1.2 Market Segment
1.2.1 by Type
1.2.1.1 PPSV 23
1.2.1.2 PCV 7/13
1.2.1.3 PCV 10
1.2.2 by Application
1.2.2.1 Infants
1.2.2.2 Children (2-10)
1.2.2.3 Person (10-64)
1.2.2.4 The old (≥65)
1.2.3 by Regions
2 Industry Chain
2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
2.3.1 SWOT
2.3.2 Dynamics
3 Environmental Analysis
3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry
4 Market Segmentation by Type
4.1 Market Size
4.1.1 PPSV 23 Market, 2013-2018
4.1.2 PCV 7/13 Market, 2013-2018
4.1.3 PCV 10 Market, 2013-2018
4.2 Market Forecast
4.2.1 PPSV 23 Market Forecast, 2019-2024
4.2.2 PCV 7/13 Market Forecast, 2019-2024
4.2.3 PCV 10 Market Forecast, 2019-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Infants Market, 2013-2018
5.1.2 Children (2-10) Market, 2013-2018
5.1.3 Person (10-64) Market, 2013-2018
5.1.4 The old (≥65) Market, 2013-2018
5.2 Market Forecast
5.2.1 Infants Market Forecast, 2019-2024
5.2.2 Children (2-10) Market Forecast, 2019-2024
5.2.3 Person (10-64) Market Forecast, 2019-2024
5.2.4 The old (≥65) Market Forecast, 2019-2024
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2012-2018
6.1.1.2 Asia-Pacific Market by Type
6.1.1.3 Asia-Pacific Market by Application
6.1.2 North America
6.1.2.1 North America Market, 2012-2018
6.1.2.2 North America Market by Type
6.1.2.3 North America Market by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2012-2018
6.1.3.2 Europe Market by Type
6.1.3.3 Europe Market by Application
6.1.4 South America
6.1.4.1 South America Market, 2012-2018
6.1.4.2 South America Market by Type
6.1.4.3 South America Market by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2012-2018
6.1.5.2 Middle East & Africa Market by Type
6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2019-2024
6.2.2 North America Market Forecast, 2019-2024
6.2.3 Europe Market Forecast, 2019-2024
6.2.4 South America Market Forecast, 2019-2024
6.2.5 Middle East & Africa Market Forecast, 2019-2024
7 Market Competitive
7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel
8 Major Vendors
8.1 MSD
8.2 Sanofipasteur
8.3 CDIBP
8.4 Pfizer
8.5 GSK
9 Conclusion
Table Products Segment of Pneumococcal Vaccine
Table PPSV 23 Overview
Table PCV 7/13 Overview
Table PCV 10 Overview
Table Global Pneumococcal Vaccine Market by Type, 2011-2022 (USD Million)
Table Application Segment of Pneumococcal Vaccine
Table Infants Overview
Table Children (2-10) Overview
Table Person (10-64) Overview
Table The old (≥65) Overview
Table Global Pneumococcal Vaccine Market by Application, 2011-2022 (USD Million)
Table Global Pneumococcal Vaccine Market by Region, 2011-2022 (USD Million)
Table Cost of Pneumococcal Vaccine
Table Market Dynamics
Table Policy of Pneumococcal Vaccine
Table GDP of Major Countries
Table PPSV 23 CAGR by Revenue and Volume, 2012-2018
Table PCV 7/13 CAGR by Revenue and Volume, 2012-2018
Table PCV 10 CAGR by Revenue and Volume, 2012-2018
Table PPSV 23 CAGR by Revenue and Volume, 2012-2024
Table PCV 7/13 CAGR by Revenue and Volume, 2012-2024
Table PCV 10 CAGR by Revenue and Volume, 2012-2024
Table Infants CAGR by Revenue and Volume, 2012-2018
Table Children (2-10) CAGR by Revenue and Volume, 2012-2018
Table Person (10-64) CAGR by Revenue and Volume, 2012-2018
Table The old (≥65) CAGR by Revenue and Volume, 2012-2018
Table Global Pneumococcal Vaccine Market by Vendors, 2012-2018 (USD Million)
Table Global Pneumococcal Vaccine Market by Vendors, 2012-2018 (in Volume)
Table Global Pneumococcal Vaccine Market Share by Vendors, 2012-2018 (USD Million)
Table Global Pneumococcal Vaccine Market Share by Vendors, 2012-2018 (in Volume)
Table Price Factors List
Table MSD Profile List
Table Microecological Modulator Operating Data of MSD (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Sanofipasteur Profile List
Table Microecological Modulator Operating Data of Sanofipasteur (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table CDIBP Profile List
Table Microecological Modulator Operating Data of CDIBP (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Profile List
Table Microecological Modulator Operating Data of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
